NCT06412185View on ClinicalTrials.gov

Single Dose Escalation Study of CM383 in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 28, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Alzheimer Disease
Interventions
BIOLOGICAL

CM383

CM383 Injection

OTHER

Placebo

Placebo

Trial Locations (1)

Unknown

RECRUITING

Jinan Central Hospital, Jinan

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06412185 - Single Dose Escalation Study of CM383 in Healthy Volunteers | Biotech Hunter | Biotech Hunter